1. Home
  2. BOLD vs CCM Comparison

BOLD vs CCM Comparison

Compare BOLD & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • CCM
  • Stock Information
  • Founded
  • BOLD 2018
  • CCM 1997
  • Country
  • BOLD United States
  • CCM China
  • Employees
  • BOLD N/A
  • CCM N/A
  • Industry
  • BOLD
  • CCM Medical/Nursing Services
  • Sector
  • BOLD
  • CCM Health Care
  • Exchange
  • BOLD Nasdaq
  • CCM Nasdaq
  • Market Cap
  • BOLD 24.4M
  • CCM 33.3M
  • IPO Year
  • BOLD 2024
  • CCM 2009
  • Fundamental
  • Price
  • BOLD $1.17
  • CCM $5.25
  • Analyst Decision
  • BOLD Buy
  • CCM
  • Analyst Count
  • BOLD 3
  • CCM 0
  • Target Price
  • BOLD $4.00
  • CCM N/A
  • AVG Volume (30 Days)
  • BOLD 286.6K
  • CCM 1.8K
  • Earning Date
  • BOLD 08-11-2025
  • CCM 04-25-2025
  • Dividend Yield
  • BOLD N/A
  • CCM N/A
  • EPS Growth
  • BOLD N/A
  • CCM N/A
  • EPS
  • BOLD N/A
  • CCM N/A
  • Revenue
  • BOLD N/A
  • CCM $52,603,198.00
  • Revenue This Year
  • BOLD N/A
  • CCM N/A
  • Revenue Next Year
  • BOLD N/A
  • CCM N/A
  • P/E Ratio
  • BOLD N/A
  • CCM N/A
  • Revenue Growth
  • BOLD N/A
  • CCM N/A
  • 52 Week Low
  • BOLD $1.00
  • CCM $3.80
  • 52 Week High
  • BOLD $4.72
  • CCM $10.50
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • CCM 33.93
  • Support Level
  • BOLD N/A
  • CCM $5.50
  • Resistance Level
  • BOLD N/A
  • CCM $5.68
  • Average True Range (ATR)
  • BOLD 0.00
  • CCM 0.18
  • MACD
  • BOLD 0.00
  • CCM 0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • CCM 21.79

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

Share on Social Networks: